Researchers at McGill University have developed an AI tool that can identify rare groups of cells responsible for driving aggressive cancer progression. The tool, called SIDISH, offers a new way to distinguish which cells within a tumour are most strongly linked to poor patient outcomes. Thuis is an important step toward more precise and effective treatments.
Healthcare innovation continues to evolve at an extraordinary pace — driven by advances in AI, digital health, virtual care, and new models of medical education.
At the centre of many of these conversations is Prof. Shafi Ahmed, our Chairman and…
Owkin and Sanofi are expanding their artificial intelligence collaboration through a multi-year agreement to co-develop AI-enabled biopharma agents for drug research and development.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us